Biomarin Pharmaceutical Inc [BMRN] Records 50-Day SMA of $64.93

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Biomarin Pharmaceutical Inc shares valued at $17,723 were sold by Hubbard Cristin on May 02 ’25. At $64.92 per share, Hubbard Cristin sold 273 shares. The insider’s holdings dropped to 32,700 shares worth approximately $1.92 million following the completion of this transaction.

Also, Hubbard Cristin purchased 273 shares, netting a total of over 17,723 in proceeds.

Before that, Burkhart Erin had sold 1,295 shares from its account. In a trade valued at $92,618, the GVP, Chief Accounting Officer traded Biomarin Pharmaceutical Inc shares for $71.52 each. Upon closing the transaction, the insider’s holdings decreased to 1,295 shares, worth approximately $1.0 million.

As published in a research note from Oppenheimer on February 24, 2025, Biomarin Pharmaceutical Inc [BMRN] has been rated up from a Perform to an Outperform and the price target has been revised to $98. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of October 30, 2024, William Blair has decreased its “an Outperform” rating to a “Mkt perform” for BMRN.

Analyzing BMRN Stock Performance

During the last five days, there has been a drop of approximately -1.05%. Over the course of the year, Biomarin Pharmaceutical Inc shares have dropped approximately -10.70%. Shares of the company reached a 52-week high of $73.51 on 03/07/25 and a 52-week low of $52.93 on 04/09/25. A 50-day SMA is recorded $64.93, while a 200-day SMA reached $69.87.

Support And Resistance Levels for Biomarin Pharmaceutical Inc (BMRN)

According to the 24-hour chart, there is a support level at 58.14, which, if violated, would cause prices to drop to 57.57. In the upper region, resistance lies at 59.65. The next price resistance is at 60.59. RSI (Relative Strength Index) is 40.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.30, which suggests the price will decrease in the coming days. Percent R is at 97.38%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.